5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Coronary Artery and Vascular Diseases
Coronary artery and vascular diseases are leading causes of morbidity and mortality worldwide, affecting the arteries that supply blood to the heart and other vital organs. Conditions such as coronary artery disease (CAD), atherosclerosis, and peripheral vascular disease (PVD) develop when plaque builds up in the arteries, narrowing blood flow and increasing the risk of heart attacks, strokes, and other complications. Early detection through advanced imaging techniques and regular monitoring of risk factors such as high cholesterol, blood pressure, and smoking is essential for effective prevention. Treatment often involves a combination of medications, lifestyle changes, and in some cases, surgical interventions like angioplasty or bypass surgery, which restore proper blood flow and reduce the risk of severe cardiovascular events.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain